This issue of our Policy Forum (Volume 3, Number 8, April 24, 2013) — In the Aftermath of Parens Patriae: Can Private Copycats Still Sue? — explains that pharma...read more
In this issue of our Policy Forum (Volume 3, Number 5, March 13, 2013) – Out on a Limb: How Will the Prohibition of Biomedical Research Using Chimpanzees Harm Public Health? – examines ...read more
This issue of Policy Forum (Volume 3, Number 4, February 27, 2013) explains the requirements under the Patient Protection and Affordable Health Care Act’s Physician Payment Sunshine...read more
This issue of Policy Forum (Volume 3, Number 3, February 13, 2013) — "What Does the Second Circuit’s Recent Decision in United States v. Caronia Not Say?" — deconstructs the landm...read more
This issue of Policy Forum (Volume 3, Number 2, January 23, 2013) – “Should DEA Provide Guidance and Conduct Rulemaking on Suspicious Orders to Ensure a Balanced Approach to Reduce...read more
In this issue of our Policy Forum (Volume 2, Number 24, December 26, 2012) – Enforcement Discretion: How Can FDA More Reasonably Regulate Autologous Stem Cell Procedures?”- summarizes h...read more
This issue of Policy Forum (Volume 2, Number 23, December 12, 2012), The Role of the Pharmacist Revisited: Should the Changing Role of Health Care Impart the Obligation of a Pharmacist to Warn?, pr...read more
In this issue of Policy Forum (Volume 2, Number 22, November 28, 2012), “It’s All About the Name: What is the Imperative of Adopting Unique Names for Biologic and Biosimilar Therapeutic...read more
by Victoria W. Girard The next issue of Policy Forum (Volume 2, Number 20, October 24, 2012), Reducing Unlawful Prescription Drug Promotion: Is the Public Health Being Served by an Enforcement...read more
by Marc Boutin Policy Forum (Volume 2, Number 15, August 8, 2012) explores implementation options for the long-awaited Prescription Drug User Fee Act V (PDUFA V) – How Should FDA Align B...read more